Sangamo Therapeutics

9 followers

For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases.

Industries

Employees

201-500

Links


Org chart

Collapse
Scott Willoughby
General Counsel & Corporate Secretary
Nathalie Dubois-Stringfellow
Senior Vice President, Product Development and Management
Stephanie J. Seiler
Head, Business Development & Alliance Management

Board & advisors

H. Stewart Parker
Chairwoman of the Board
James R. Meyers
President and Chief Executive Officer, IntraBio
John Markels
Director
Karen Smith
Director
Robert F. Carey
President and Chief Operating Officer, Acelyrin, Inc.